GlassScriptPhysician profile
Christopher J Marrocco
NPI 1124208459
$81,116.50
in general payments reported to CMS, 2019-2025
32 companies · $16K in 2025
The $16K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $839 · 2021: $15K · 2022: $17K · 2023: $16K · 2024: $15K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $45K · Food and Beverage: $3,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $45,000.00 |
| Food and Beverage | $3,114.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $74,795.45 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Alphavac |
| Organogenesis INC. | $2,023.41 | 2021-2024 | Puraply |
| Endologix LLC | $927.00 | 2019-2025 | Endocross Device, Torus Stent Graft System |
| Philips North America LLC | $398.18 | 2019-2023 | |
| Boston Scientific Corporation | $389.88 | 2019-2025 | Eluvia, Varithena Administration Pack, Emblem Mri S-Icd |
| Koya Medical, INC. | $384.66 | 2023 | Dayspring |
| Medtronic Vascular, INC. | $376.50 | 2019-2020 | |
| Medtronic, INC. | $294.01 | 2022-2025 | Endurant Iis, Turbohawk, Venaseal |
| Shockwave Medical, INC | $244.44 | 2019-2025 | |
| Lemaitre Vascular, INC. | $205.12 | 2019-2025 | Trivex System, Artegraft Vascular Graft, Restoreflow |
| Bard Peripheral Vascular, INC. | $153.72 | 2020-2025 | Rotarexs 6 F X 135 Cm |
| Terumo Medical Corporation | $140.34 | 2019-2023 | Glidewire |
| Cardiovascular Systems INC. | $104.99 | 2019-2021 | |
| Penumbra, INC. | $103.18 | 2019 | |
| Inari Medical, INC. | $74.50 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $54.06 | 2019-2023 | Rosen |
| Venclose INC. | $46.73 | 2020 | |
| W. L. Gore & Associates, INC. | $43.23 | 2019 | |
| Smith+Nephew, INC. | $34.47 | 2025 | Collagenase Santyl |
| Getinge USA Sales, LLC | $31.60 | 2020 | |
| Ethicon US, LLC | $31.41 | 2019-2021 | |
| Cvrx, INC. | $31.30 | 2024 | Barostim Neo System |
| Acell, INC. | $30.00 | 2020 | |
| Cardiva Medical, INC. | $29.38 | 2020 | |
| Merit Medical Systems INC | $27.10 | 2024 | Hero Graft, Surfacer Inside-Out Catheter |
| Pfizer INC. | $26.63 | 2024 | |
| Abbott Laboratories | $26.03 | 2023 | Diamondback Peripheral |
| Acera Surgical, INC. | $24.94 | 2022 | |
| Becton, Dickinson and Company | $24.26 | 2024 | Rotarexs 6 F X 135 Cm |
| Biotronik INC. | $22.65 | 2023 | Oscar |
| Ascensia Diabetes Care US INC. | $17.33 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Marrocco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.